The Pharmaceutical Research and Manufacturers of America (PhRMA) has testified to the US Senate Special Committee on Aging, about the value of drug marketing.
Marjorie Powell, the PhRMA's senior assistant general counsel, told the hearing that "pharmaceutical marketing plays a critical role in improving patient care and fostering the appropriate use of medicines that helps lower overall health care costs in America. Arming physicians with essential information about the medicines they prescribe undoubtedly benefits patients and advances health care in the United States."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze